Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06482333
NA

Timing of Resumption of Direct Oral Anticoagulants Following Polypectomy

Sponsor: The University of Hong Kong

View on ClinicalTrials.gov

Summary

The goal of this prospective randomized non-inferiority trial is to compare two different resumption time of Direct Oral Anticoagulants (DOACs) after colonoscopic polypectomy. We hypothesize that early resumption of DOACs after colonoscopy and polypectomy is associated with comparable post-polypectomy bleeding rate to those with delayed resumption. This study aims to compare the post-polypectomy bleeding risk of two different timing of resuming DOACs (Day 0 vs Day 2):

Official title: Timing of Resumption of Direct Oral Anticoagulants Following Colonoscopy Polypectomy: a Prospective Randomized Non-inferiority Trial

Key Details

Gender

All

Age Range

40 Years - Any

Study Type

INTERVENTIONAL

Enrollment

194

Start Date

2024-10-03

Completion Date

2026-12-31

Last Updated

2024-12-11

Healthy Volunteers

No

Interventions

OTHER

Time for resumption of DOAC

Time for resumption of DOAC

Locations (1)

Queen Mary Hospital, the University of Hong Kong

Hong Kong, Hong Kong